It's been a while since the pharmaceutical industry last saw a year like 2023, when the U.S. Food and Drug Administration (FDA) approved a slew of groundbreaking and life-changing medications that represent a surge in innovation-and a potential boon to the drugmakers' bottom lines.
Eisai and Biogen kicked off the year with the approval of lecanemab (Leqembi) for Alzheimer's disease, which is the second medication designed to treat the root causes of the memory-robbing condition, but appears to be the most effective. GSK and Pfizer dropped the first-ever vaccines for RSV in adults, giving older and pregnant people a way to protect themselves and, in the case of expectant mothers, their newborns as well-from a potentially deadly respiratory disease. Biogen and Sage Therapeutics received approval for a first-ever oral treatment for postpartum depression, zuranolone (Zurzuvae), and the FDA also allowed biotech companies Intellia Therapeutics and Regeneron Pharmaceuticals to start late-stage testing of the first gene-editing treatment, using CRISPR technology, inside patients.
Esta historia es de la edición December 25, 2023 de Time.
Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.
Ya eres suscriptor ? Conectar
Esta historia es de la edición December 25, 2023 de Time.
Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.
Ya eres suscriptor? Conectar
Freshwater reserves
A troubling dip
Broadcasting a crisis for the world to see
ON SEPT. 5, 1972, A 32-YEAR-OLD PRODUCER NAMED Geoffrey S. Mason was working in a control room for ABC Sports in Munich while 12 hostages, including several members of the Israeli Olympic delegation, were being held in a building nearby.
QUEERING THE STORY
Luca Guadagnino directs Daniel Craig in an adaptation of William S. Burroughs' 1985 novella Queer
Turkey's Erdogan plots his next power grab
RECEP TAYYIP Erdogan is a political survivor.
Why maiden names matter in the age of AI and identity
IN THE DIGITAL AGE, A NAME IS MORE THAN JUST A label. It's tied to our professional history and social media presence.
MAKE ROOM AT YOUR TABLE
Thanksgiving is a time for celebration with our families and communities— but for the millions of Americans who are living with hunger, it can be an intensely difficult reminder of their daily challenges.
5 ways to embrace winter-even if you usually dread it
WHEN KARI LEIBOWITZ MOVED TO the Arctic in 2014, she braced herself for the impact of long, dark, cold winters.
New guidance for teens and screens
SCREENS ARE PART OF MODERN TEENage life but there are almost no guardrails around what they see.
THE CLIMATE VACUUM
A U.S. retreat won't stop global climate efforts, but even the leaders who met at COP29 don't know what's coming next
Say Nothing speaks volumes
IN 1972, AT THE BLOODY HEIGHT OF the Troubles, home invaders abducted a widowed mother of 10 named Jean McConville from her Belfast apartment. Her children never saw her alive again.
